×
About 6,938 results

ALLMedicine™ Haemophilus Influenzae Center

Research & Reviews  1,596 results

Non-typeable Haemophilus influenzae-Moraxella catarrhalis vaccine for the prevention of...
https://doi.org/10.1016/S2213-2600(21)00502-6
The Lancet. Respiratory Medicine; Andreas S, Testa M et. al.

Jan 14th, 2022 - Acute exacerbations of chronic obstructive pulmonary disease (AECOPD) are associated with changes in the sputum microbiome, including an increased prevalence of pathogenic bacteria. Vaccination against the most frequent bacteria identified in AECO...

Haemophilus influenzae Serotype a as a Cause of Meningitis in Children in Brazil.
https://doi.org/10.1097/INF.0000000000003391 10.1155/2013/941461
The Pediatric Infectious Disease Journal; Russo DO, Torres BR et. al.

Jan 13th, 2022 - Since the introduction of Haemophilus influenzae type b vaccines, invasive disease due to Haemophilus influenzae serotype a (Hia) has been reported with increasing frequency. This study is based on hospital-based surveillance for Hia meningitis ov...

Systematic review of the efficacy, effectiveness and impact of high-valency pneumococca...
https://doi.org/10.1080/21645515.2021.2013693
Human Vaccines & Immunotherapeutics; Izurieta P, Scherbakov M et. al.

Jan 13th, 2022 - Otitis media (OM) is a common disease of childhood and available pneumococcal conjugate vaccines (PCVs), with different compositions, could have different impact on OM reduction. This systematic literature review evaluated available data describin...

Nasopharyngeal colonisation dynamics of bacterial pathogens in patients with fever in r...
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8725287
BMC Infectious Diseases; Martens L, Kaboré B et. al.

Jan 6th, 2022 - Nasopharyngeal colonisation with clinically relevant bacterial pathogens is a risk factor for severe infections, such as pneumonia and bacteraemia. In this study, we investigated the determinants of nasopharyngeal carriage in febrile patients in r...

Evaluation of the indirect impact of the 10-valent pneumococcal Haemophilus influenzae ...
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8730423
PloS One; Rinta-Kokko H, Palmu AA et. al.

Jan 6th, 2022 - In the nation-wide double-blind cluster-randomised Finnish Invasive Pneumococcal disease trial (FinIP, ClinicalTrials.gov NCT00861380, NCT00839254), we assessed the indirect impact of the 10-valent pneumococcal Haemophilus influenzae protein D con...

see more →

Guidelines  4 results

Licensure of a Diphtheria and Tetanus Toxoids and Acellular Pertussis, Inactivated Poli...
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7004397
MMWR. Morbidity and Mortality Weekly Report; Oliver SE, Moore KL

Feb 7th, 2020 - On December 21, 2018 the Food and Drug Administration (FDA) licensed a hexavalent combined diphtheria and tetanus toxoids and acellular pertussis (DTaP) adsorbed, inactivated poliovirus (IPV), Haemophilus influenzae type b (Hib) conjugate (meningo...

Prevention and control of meningococcal disease: recommendations of the Advisory Commit...
https://www.ncbi.nlm.nih.gov/pubmed/23515099
MMWR. Recommendations and Reports : Morbidity and Mortali... Cohn AC, MacNeil JR et. al.

Mar 22nd, 2013 - Meningococcal disease describes the spectrum of infections caused by Neisseria meningiditis, including meningitdis, bacteremia, and bacteremic pneumonia. Two quadrivalent meningococcal polysaccharide-protein conjugate vaccines that provide protect...

Recommendations for treatment of childhood non-severe pneumonia.
https://doi.org/10.1016/S1473-3099(09)70044-1
The Lancet. Infectious Diseases; Grant GB, Campbell H et. al.

Feb 28th, 2009 - WHO recommendations for early antimicrobial treatment of childhood pneumonia have been effective in reducing childhood mortality, but the last major revision was over 10 years ago. The emergence of antimicrobial resistance, new pneumonia pathogens...

Licensure of a diphtheria and tetanus toxoids and acellular pertussis adsorbed, inactiv...
https://www.ncbi.nlm.nih.gov/pubmed/18830213
MMWR. Morbidity and Mortality Weekly Report;

Oct 3rd, 2008 - On June 20, 2008 the Food and Drug Administration (FDA) licensed a combined diphtheria and tetanus toxoids and acellular pertussis adsorbed (DTaP), inactivated poliovirus vaccine (IPV), and Haemophilus influenzae type b conjugate (tetanus toxoid [...

see more →

Drugs  962 results see all →

Clinicaltrials.gov  30 results

A Phase 3 Study of BIBP Diphtheria, Tetanus and Acellular Pertussis (Three Components) Combined Vaccine, Adsorbed
https://clinicaltrials.gov/ct2/show/NCT05091619

Oct 27th, 2021 - The study will evaluate the safety, immunogenicity,immune persistence and lot-to-lot consistency of Diphtheria,Tetanus and Acellular Pertussis (Three Components) Combined Vaccine, Adsorbed, (DTacP) including 2 parts: PART 1 will evaluate the safe...

A Study to Evaluate Immunogenicity and Safety of GlaxoSmithKline (GSK)'s Infanrix Hexa Vaccine (DTPa-HBV-IPV/Hib) Versus MCM Vaccine BV's Vaxelis Vaccine (DTaP5-HBV-IPV-Hib) in Healthy Infants and ...
https://clinicaltrials.gov/ct2/show/NCT04535037

Apr 8th, 2021 - The purpose of this study is to assess the safety and immunogenicity of GSK's combined diphtheria, tetanus, acellular pertussis, hepatitis B, inactivated poliovirus and Haemophilus influenzae type b conjugate vaccine (DTPa-HBV-IPV/Hib) versus MCM ...

Vaccination Coverage and Level of Protection in Patients at Risk
https://clinicaltrials.gov/ct2/show/NCT03820752

Oct 23rd, 2020 - Chronically ill children 1.1 What is the vaccination status for vaccines recommended by the Superior Health Council in pediatric chronically ill patients (2-16 years of age) who consult within the University hospital of Leuven? Patients with one o...

Understanding How Salmonella Typhi Infects Humans (Bottlenecks)
https://clinicaltrials.gov/ct2/show/NCT03889067

Oct 20th, 2020 - The pathogenesis of bacteraemia for human restricted pathogens such as Streptococcus pneumoniae, Haemophilus influenzae type b and Salmonella enterica serovar Typhi (ST), have thus far only been investigated in imperfect animal models. The Salmone...

Hepatitis B Vaccination in Infants
https://clinicaltrials.gov/ct2/show/NCT01896596

Oct 1st, 2020 - Infants in the United Kingdom are routinely immunised against diphtheria, tetanus, pertussis (whooping cough), polio and Haemophilus influenzae type b (Hib) as a single 5-in-1 (DTaP5-IPV-Hib) combination vaccine given as a 2-3-4 month schedule. Th...

see more →

News  178 results

The Etiology of Acute Otitis Media in Young Children in Recent Years
https://www.medscape.com/viewarticle/966498

Jan 12th, 2022 - Since the COVID-19 pandemic began, pediatricians have been seeing fewer cases of all respiratory illnesses, including acute otitis media (AOM). However, as I prepare this column, an uptick has commenced and likely will continue in an upward trajec...

Clinical Edge Journal Scan Commentary: CAP December 2021
https://www.mdedge.com/chestphysician/article/249456/community-acquired-pneumonia/clinical-edge-journal-scan-commentary-cap
Russell W. Steele, MD, MDedge News

Dec 4th, 2021 - Although the majority of acute pneumonias are viral in etiology, standard practice dictates empiric administration of antimicrobial agents for the youngest, oldest, and patients with underlying comorbid conditions. The practitioner’s primary respo.

Managing Simple Febrile Seizures Without Lumbar Puncture Safe: 15-Year Study
https://www.medscape.com/viewarticle/962096

Nov 2nd, 2021 - Most children with simple febrile seizures (SFSs) can be safely managed without lumbar puncture or other diagnostic tests without risking delayed diagnosis of bacterial meningitis, new data gathered from a 15-year span suggest. Vidya R. Raghavan, ...

WHO Unveils Global Roadmap to Defeat Meningitis by 2030
https://www.medscape.com/viewarticle/960501

Oct 8th, 2021 - The World Health Organization (WHO) and its partners recently released an ambitious plan, the Global Roadmap to Defeat Meningitis by 2030. Their goal is to reduce deaths and disabilities from bacterial meningitis, which kills about 250,000 people ...

High Antimicrobial Use Seen in COVID Patients During First Wave
https://www.medscape.com/viewarticle/952344

Jun 3rd, 2021 - Use of antimicrobials among COVID-19 patients should be assisted by clear guidelines to reduce the risk of drug-resistance, experts said. Patients had a median age of 74. The timing of infection was recorded either as occurring prior to hospitalis...

see more →

Patient Education  5 results see all →